CryOSA
Arden Hills, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into CryOSA
270 people in our graph share verified history with the CryOSA team — schools, employers, funds. One of them is your warm intro.
Roger Hurwitzunlockedknows Laura Stoltenberg · together at GE (overlapped)
×7knows the team · via Bucknell University
×2knows the team · via GE
×2knows the team · via Columbia Business School
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
Founders & leadership
LS
Laura StoltenberginExecutiveLaura Stoltenberg is an executive with experience in medical devices, life sciences, and health care IT, having held general management, business development, and P&L leadership roles across commercial and strategic planning functions. She has worked with FDA, payers, and health care providers and led teams that developed products demonstrating clinical and economic outcomes.
Board
DB
DF
Doug FrenchBoard director
JE
James EadieBoard director
DG
Donald GonzalesFounder and Chief Medical Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$7M disclosed across 2 rounds · 2018–2025
▶$6MraisedAug 2025 · 20 investors · BiotechnologyRule 506(b)
▶$6MraisedAug 2025 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug FrenchDirector
- James EadieDirector
- Donald GonzalesDirector
- David BelitzDirector
- Laura StoltenbergExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $6M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$997.3KraisedMay 2018 · 6 investors · Other Health CareRule 506(b)
▶$997.3KraisedMay 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald GonzalesExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $997.3K
- Minimum investment
- $1
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does CryOSA do?
- Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
- Who are CryOSA's investors?
- CryOSA's investors include Brightstone Venture Capital, Solas BioVentures.
- How much funding has CryOSA raised?
- CryOSA has disclosed $7M raised across 2 rounds.
- Where is CryOSA headquartered?
- CryOSA is headquartered in Arden Hills, US.